ACELYRIN Announces Appointment of Patrick Machado, JD to Board of Directors

LOS ANGELES: LOS ANGELES, June 10, 2021 /PRNewswire/ -- ACELYRIN, INC., a biopharma company focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of promising drug candidates, today announced the appointment of Patrick (Pat) Machado, JD to its board of directors. Mr. Machado...

Click to view original post